Physician profile
Ajaz Sheikh
NPI 1932401221
$3,570.73
in general payments reported to CMS, 2019-2025
41 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $94.38 · 2021: $312 · 2022: $621 · 2023: $563 · 2024: $1,327 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,105 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,105.12 |
| Education | $223.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $464.30 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Jazz Pharmaceuticals INC. | $392.02 | 2019-2024 | Epidiolex |
| Ucb, INC. | $380.53 | 2022-2025 | Briviact, Nayzilam, Rystiggo |
| Neuropace, INC. | $316.35 | 2024-2025 | |
| Sk Life Science, INC. | $241.92 | 2021-2025 | |
| Neurelis, INC. | $233.39 | 2021-2025 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $152.05 | 2019-2025 | Austedo Xr, Austedo Xr |
| Eisai INC. | $132.10 | 2022-2024 | |
| Celgene Corporation | $120.74 | 2022-2023 | Zeposia |
| Biocodex, INC. | $111.75 | 2024-2025 | |
| Harmony Biosciences LLC | $96.91 | 2023-2024 | Wakix |
| Novartis Pharmaceuticals Corporation | $75.15 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $66.00 | 2019-2025 | Ultomiris |
| Acadia Pharmaceuticals INC | $60.38 | 2022-2024 | Nuplazid |
| Takeda Pharmaceuticals U.S.A., INC. | $58.41 | 2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajaz Sheikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.